Comparison of the IHC Expression of p16, p53, and MIB-1 in Extragenital Skin Bowenoid Lesions With High- and Low- Chronic Sun Damage

  • 0Department of Dermatology, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.

|

|

Summary

This summary is machine-generated.

p16, p53, and MIB-1 staining patterns may help differentiate high-chronic sun damage (H-CSD) bowenoid lesions. Histopathology alone may not distinguish between H-CSD and low-CSD lesions or Bowen disease and bowenoid actinic keratosis.

Area Of Science

  • Dermatopathology
  • Oncology
  • Molecular Biology

Background

  • Distinguishing Bowen disease from bowenoid actinic keratosis is challenging due to overlapping histopathology.
  • Chronic sun damage (CSD) influences lesion development and presentation.
  • Immunohistochemical markers like p16, p53, and MIB-1 are explored for diagnostic utility.

Purpose Of The Study

  • To evaluate the role of p16, p53, and MIB-1 staining patterns in differentiating high-chronic sun damage (H-CSD) from low-chronic sun damage (L-CSD) bowenoid lesions.
  • To assess the utility of these markers in distinguishing between Bowen disease and bowenoid actinic keratosis.
  • To investigate potential differences in dysplasia pathways based on marker expression.

Main Methods

  • Sixty extragenital in situ squamous cell carcinomas were analyzed.
  • Lesions were classified as H-CSD or L-CSD based on the presence of elastosis.
  • P16, p53, and MIB-1 staining patterns (block, gradient, focal) were assessed.

Main Results

  • Seventy-two percent of lesions were classified as H-CSD.
  • P16 staining was positive in 80% and p53 in 47%, with block patterns more frequent in H-CSD lesions (P=0.047 for p16, P=0.02 for p53).
  • MIB-1 was positive in all cases, and p16/MIB-1 patterns coincided in 75%.

Conclusions

  • P16 and p53 expression may be less frequent in bowenoid lesions than previously reported.
  • Basal layer and adnexal/follicular involvement may not reliably differentiate H-CSD from L-CSD lesions.
  • Variations in p16, p53, and MIB-1 staining suggest distinct dysplasia pathways requiring further prognostic investigation.